On the potentiation of kinins by sulfhydrylic compounds.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology*; D003543:Cysteamine / Q000494:pharmacology*; D003545:Cysteine / Q000494:pharmacology*; D004112:Dimercaprol / Q000494:pharmacology*; D004357:Drug Synergism; D004600:Eledoisin / Q000494:pharmacology*; D006168:Guinea Pigs; D007082:Ileum; D066298:In Vitro Techniques; D007609:Kallidin / Q000494:pharmacology*; D008623:Mercaptoethanol / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects*; D000338:beta-Aminoethyl Isothiourea / Q000494:pharmacology*
D004112:Dimercaprol; D000804:Angiotensin II; D000338:beta-Aminoethyl Isothiourea; D007609:Kallidin; D003543:Cysteamine; D008623:Mercaptoethanol; D004600:Eledoisin; D003545:Cysteine; D001920:Bradykinin